Overexpression of SLC35F2 is a potential prognostic biomarker for lung adenocarcinoma

Overexpression of SLC35F2 is a potential prognostic biomarker for lung adenocarcinoma

Objective: To explore the potential clinical and prognostic significance of Homo sapiens solute carrier family 35 member F2 (SLC35F2) in the context of lung adenocarcinoma (LUAD). Methods: The expression pattern of SLC35F2 in LUAD tissues and normal tissues was analyzed in The Cancer Genome Atlas (T...

Full description

Bibliographic Details
Main Authors:	Qingzhu Zheng, Mingjie Li, Yingkun Qiu, Jiahao Yang, Yingping Cao
Format:	Article
Language:	English
Published:	Elsevier 2024-01-01
Series:	Heliyon
Subjects:	LUAD SLC35F2 The cancer genome Atlas Biomarker Prognosis
Online Access:	http://www.sciencedirect.com/science/article/pii/S240584402311036X

Similar Items

RS1 gene is a novel prognostic biomarker for lung adenocarcinoma
by: Tao Zhang, et al.
Published: (2022-06-01)

Novel Insights into the Prognosis and Immunological Value of the SLC35A (Solute Carrier 35A) Family Genes in Human Breast Cancer
by: Hoang Dang Khoa Ta, et al.
Published: (2021-11-01)

SLC35A2 expression is associated with HER2 expression in breast cancer
by: Yiran Wang, et al.
Published: (2024-04-01)

SLC35F2, a Transporter Sporadically Mutated in the Untranslated Region, Promotes Growth, Migration, and Invasion of Bladder Cancer Cells
by: Roland Kotolloshi, et al.
Published: (2021-01-01)

TCN1 is a potential prognostic biomarker and correlates with immune infiltrates in lung adenocarcinoma
by: Haining Li, et al.
Published: (2022-03-01)

EZH2 as a prognostic-related biomarker in lung adenocarcinoma correlating with cell cycle and immune infiltrates
by: Kui Fan, et al.
Published: (2023-04-01)

Identification of cuproptosis and immune-related gene prognostic signature in lung adenocarcinoma
by: Wentao Zhang, et al.
Published: (2023-08-01)

SLC7A11 inhibits ferroptosis and downregulates PD-L1 levels in lung adenocarcinoma
by: Zhenyao Huang, et al.
Published: (2024-04-01)

MRPL12 Acts as A Novel Prognostic Biomarker Involved in Immune Cell Infiltration and Tumor Progression of Lung Adenocarcinoma
by: Yangyang Hu, et al.
Published: (2023-02-01)

Development and validation of a survival model for lung adenocarcinoma based on autophagy-associated genes
by: Xiaofei Wang, et al.
Published: (2020-04-01)

SLC35A2-CDG: Novel variant and review
by: Dulce Quelhas, et al.
Published: (2021-03-01)

<i>N</i>-Glycoprofiling of SLC35A2-CDG: Patient with a Novel Hemizygous Variant
by: Rebeka Kodríková, et al.
Published: (2023-02-01)

Correlation analysis between SLC52A2 gene expression and prognosis of patients with uveal melanoma
by: Xiao-Cui Liang, et al.
Published: (2023-08-01)

SLC6A8 is a Potential Biomarker for Poor Prognosis in Lung Adenocarcinoma
by: Yongfei Fan, et al.
Published: (2022-05-01)

Clinical Prognostic Value of the PLOD Gene Family in Lung Adenocarcinoma
by: Yiming Meng, et al.
Published: (2022-02-01)

NcRNA-regulated CAPZA1 associated with prognostic and immunological effects across lung adenocarcinoma
by: Tingting Qin, et al.
Published: (2023-01-01)

DNA methylation molecular subtypes for prognosis prediction in lung adenocarcinoma
by: Duoduo Xu, et al.
Published: (2022-04-01)

Upregulation of CCT3 predicts poor prognosis and promotes cell proliferation via inhibition of ferroptosis and activation of AKT signaling in lung adenocarcinoma
by: Kun Wang, et al.
Published: (2022-06-01)

Effects of Interaction between <i>SLC35F3</i> and Carbohydrate Intake on the Incidence of Metabolic Syndrome in Korean Middle-Aged Adults
by: Haeun Park, et al.
Published: (2023-01-01)

Leveraging a disulfidptosis/ferroptosis-based signature to predict the prognosis of lung adenocarcinoma
by: Xiaoqing Ma, et al.
Published: (2023-11-01)

LATPS, a novel prognostic signature based on tumor microenvironment of lung adenocarcinoma to better predict survival and immunotherapy response
by: Jihong Huang, et al.
Published: (2022-11-01)

Prognostic correlation between specialized capillary endothelial cells and lung adenocarcinoma
by: Rongchang Zhao, et al.
Published: (2024-03-01)

Function and prognostic value of basement membrane -related genes in lung adenocarcinoma
by: Yurong Zhang, et al.
Published: (2023-05-01)

Establishment of a Prognostic Model of Lung Adenocarcinoma Based on Tumor Heterogeneity
by: Pengdou Zheng, et al.
Published: (2022-04-01)

Inhibition of the SLC35B2–TPST2 Axis of Tyrosine Sulfation Attenuates the Growth and Metastasis of Pancreatic Ductal AdenocarcinomSummary
by: Xinran Cai, et al.
Published: (2023-01-01)

Abnormal TACC3 Expression is an Independent Prognostic Biomarker in Lung Carcinoma
by: Xiangmei Zhang, et al.
Published: (2022-08-01)

A Comprehensive Prognostic and Immune Analysis of SLC41A3 in Pan-Cancer
by: Jun Liu, et al.
Published: (2021-01-01)

Comprehensive Analysis of SLC35A2 in Pan-Cancer and Validation of Its Role in Breast Cancer
by: Sun X, et al.
Published: (2023-08-01)

High DSCC1 Level Predicts Poor Prognosis of Lung Adenocarcinoma
by: Chang S, et al.
Published: (2021-10-01)

MMR gene patterns evaluation provides novel insights for personalized immunotherapy compared to neoadjuvant chemotherapy in lung adenocarcinama
by: Liangliang Cai, et al.
Published: (2023-06-01)

Integrative Multi-Omics Analysis of Identified SKA3 as a Candidate Oncogene Correlates with Poor Prognosis and Immune Infiltration in Lung Adenocarcinoma
by: Lin Y, et al.
Published: (2022-05-01)

Molecular cloning of SLC35D3 and analysis of its role during porcine intramuscular preadipocyte differentiation
by: Wentong Li, et al.
Published: (2020-02-01)

Identification of Extracellular Matrix Signatures as Novel Potential Prognostic Biomarkers in Lung Adenocarcinoma
by: Zhen Zeng, et al.
Published: (2022-05-01)

Delivery of Nucleotide Sugars to the Mammalian Golgi: A Very Well (un)Explained Story
by: Dorota Maszczak-Seneczko, et al.
Published: (2022-08-01)

The Tumorigenic Effect of the High Expression of Ladinin-1 in Lung Adenocarcinoma and Its Potential as a Therapeutic Target
by: Lei Hu, et al.
Published: (2023-01-01)

The pattern of alternative splicing in lung adenocarcinoma shows novel events correlated with tumorigenesis and immune microenvironment
by: Gongjun Wang, et al.
Published: (2021-12-01)

A Novel Prognostic and Predictive Signature for Lung Adenocarcinoma Derived from Combined Hypoxia and Infiltrating Immune Cell-Related Genes in TCGA Patients
by: Wu X, et al.
Published: (2021-12-01)

A novel long noncoding RNA (lncRNA), LINC02657(LASTR), is a prognostic biomarker associated with immune infiltrates of lung adenocarcinoma based on unsupervised cluster analysis
by: Fanming Kong, et al.
Published: (2023-11-01)

MDFI is a novel biomarker for poor prognosis in LUAD
by: Pengyu Chen, et al.
Published: (2022-10-01)

Four New Cases of SLC35A2-CDG With Novel Mutations and Clinical Features
by: Kuerbanjiang Abuduxikuer, et al.
Published: (2021-05-01)